Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALNFL.PA
- Price
- 1.38
- Stock movement up
- +0.03 (2.22%)
- Company name
- NFL Biosciences SAS
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 13.27M
- Ent value
- 12.44M
- Price/Sales
- -
- Price/Book
- 5.80
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -33.01%
- 3 year return
- 4.48%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-18
DIVIDENDS
ALNFL.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 119.59 |
| Price to FCF | 119.59 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 5.80 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 9.61M |
| EPS (TTM) | -0.60 |
| FCF per share (TTM) | 0.01 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -108.69K |
| Operating income (TTM) | -7.07M |
| Net income (TTM) | -5.85M |
| EPS (TTM) | -0.60 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.55M |
| Net receivables | 929.45K |
| Total current assets | 4.68M |
| Goodwill | 0.00 |
| Intangible assets | 163.81K |
| Property, plant and equipment | 0.00 |
| Total assets | 5.01M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 53.36K |
| Total current liabilities | 1.49M |
| Total liabilities | 2.72M |
| Shareholder's equity | 2.29M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 110.93K |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | 110.93K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -255.61% |
| Return on Assets | -116.77% |
| Return on Invested Capital | -253.07% |
| Cash Return on Invested Capital | 4.80% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.35 |
| Daily high | 1.38 |
| Daily low | 1.32 |
| Daily Volume | 13K |
| All-time high | 4.75 |
| 1y analyst estimate | 4.20 |
| Beta | - |
| EPS (TTM) | -0.60 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALNFL.PA | S&P500 | |
| Current price drop from All-time high | -70.95% | -14.12% |
| Highest price drop | -86.36% | -56.47% |
| Date of highest drop | 23 May 2022 | 9 Mar 2009 |
| Avg drop from high | -52.43% | -11.07% |
| Avg time to new high | 162 days | 12 days |
| Max time to new high | 905 days | 1805 days |
COMPANY DETAILS
Marketcap
13.27M
Marketcap category
Small-cap
Description
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. The company's natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. NFL Biosciences SA was incorporated in 2006 and is based in Castelnau-le-Lez, France.
Employees
0
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found